Filters

Clear all

Expert Opinion

Plain Language Summary

Expert Review

Text Availability

Abstract

Full text

Free full text

Publication Types

Journal Article

Research Support, Non-U.S. Gov't

Randomized Controlled Trial

Comparative Study

Review

Observational Study

Multicenter Study

Systematic Review

Clinical Trial, Phase III

Clinical Trial, Phase IV

Pragmatic Clinical Trial

Research Support, N.I.H., Extramural

Publication Year

From

Quick links

Individual year

2026

2025

2023

2022

2020

2019

2018

2017

2016

2015

2014

2013

2012

Sort by:

selected

Print page

Email selected articles

Favourite selected articles

Create a NED Search Alert for this search

Save this search

Advanced Search

Run an advanced search

Results for
""Dry Powder Inhalers""[mesh_terms]

29 Results

Searching titles within these results

Measuring Peak Inspiratory Flow in Patients with Chronic Obstructive Pulmonary Disease.

Jill A Ohar, Gary T Ferguson, Donald A Mahler, M Bradley Drummond, Rajiv Dhand, Roy A Pleasants, Antonio Anzueto, David M G Halpin, David B Price, Gail S Drescher, Haley M Hoy, John Haughney, Michael W Hess, Omar S Usmani

International journal of chronic obstructive pulmonary disease 2022;17():79-92

Free Full Text

Abstract

Safety, Tolerability, and Pharmacokinetics of a New Formulation of Nemiralisib Administered via a Dry Powder Inhaler to Healthy Individuals.

Robert Wilson, Alison Templeton, Claudia Leemereise, Rhena Eames, Edward Banham-Hall, Edith M Hessel, Anthony Cahn

Clinical therapeutics 2020;41(6):1214-1220

Full Text

Abstract

Solid Lipid Nanoparticle assemblies (SLNas) for an anti-TB inhalation treatment-A Design of Experiments approach to investigate the influence of pre-freezing conditions on the powder respirability.

Eleonora Maretti, Cecilia Rustichelli, Marcello Romagnoli, Anna Giulia Balducci, Francesca Buttini, Francesca Sacchetti, Eliana Leo, Valentina Iannuccelli

International journal of pharmaceutics 2017;511(1):669-679

Full Text

Abstract

Identifying critical inhalation technique errors in Dry Powder Inhaler use in patients with COPD based on the association with health status and exacerbations: findings from the multi-country cross-sectional observational PIFotal study.

Sinthia Bosnic-Anticevich, Biljana Cvetkovski, Richard Dekhuijzen, Asparuh Gardev, Radosław Gawlik, Federico Lavorini, Tiago Maricoto, Ioanna Tsiligianni, Jaime Correia de Sousa, David Price, Omar Usmani, Miguel Román Rodríguez, Janwillem Kocks, Joyce van Cooten, Lars Dijk, Marina Garcia Pardo, Iris van der Ham, Ymke Janse, Jiska Meijer, Boyd Metz, Kirsten Schuttel, Nilouq Stoker, Jaco Voorham, Marika T Leving

BMC pulmonary medicine 2023;23(1):302

Free Full Text

Abstract

Effect of inhaled dry powder mannitol on mucus and its clearance.

Evangelia Daviskas, Bruce K Rubin

Expert review of respiratory medicine 2013;7(1):65-75

Full Text

Abstract

Suboptimal Peak Inspiratory Flow and Critical Inhalation Errors are Associated with Higher COPD-Related Healthcare Costs.

Marika T Leving, Joyce van Cooten, Biljana Cvetkovski, Lars Dijk, Asparuh Gardev, Radosław Gawlik, Iris van der Ham, Ymke Janse, Tiago Maricoto, Jiska Meijer, Boyd Metz, Miguel Roman-Rodriguez, Kirsten Schuttel, Nilouq Stoker, Ioanna Tsiligianni, Jaime Correia de Sousa, Marina Garcia Pardo, Federico Lavorini, Job F M van Boven, Sinthia Z Bosnic-Anticevich, Richard Dekhuijzen, Elisabeth Sophia Hartgers-Gubbels, David B Price, Omar S Usmani, Janwillem H Kocks

International journal of chronic obstructive pulmonary disease 2022;17():2401-2415

Free Full Text

Abstract

Computationally efficient analysis of particle transport and deposition in a human whole-lung-airway model. Part II: Dry powder inhaler application.

Arun V Kolanjiyil, Clement Kleinstreuer, Ruxana T Sadikot

Computers in biology and medicine 2018;84():247-253

Full Text

Abstract

Use of a fundamental approach to spray-drying formulation design to facilitate the development of multi-component dry powder aerosols for respiratory drug delivery.

Susan Hoe, James W Ivey, Mohammed A Boraey, Abouzar Shamsaddini-Shahrbabak, Emadeddin Javaheri, Sadaf Matinkhoo, Warren H Finlay, Reinhard Vehring

Pharmaceutical research 2014;31(2):449-65

Full Text

Abstract

Colistimethate sodium dry powder for inhalation: a review of its use in the treatment of chronic Pseudomonas aeruginosa infection in patients with cystic fibrosis.

Gillian M Keating, Daniel Conole

Drugs 2015;74(3):377-87

Full Text

Abstract

Clinical recommendations for dry powder inhaler use in the management of COPD in primary care.

Marika T Leving, Sinthia Bosnic-Anticevich, Joyce van Cooten, Jaime Correia de Sousa, Biljana Cvetkovski, Richard Dekhuijzen, Lars Dijk, Marina Garcia Pardo, Asparuh Gardev, Radosław Gawlik, Iris van der Ham, Ymke Janse, Federico Lavorini, Tiago Maricoto, Jiska Meijer, Boyd Metz, David Price, Miguel Roman-Rodriguez, Kirsten Schuttel, Nilouq Stoker, Ioanna Tsiligianni, Omar Usmani, Rachel Emerson-Stadler, Janwillem W H Kocks

NPJ primary care respiratory medicine 2022;32(1):59

Free Full Text

Abstract

Factors associated with health status and exacerbations in COPD maintenance therapy with dry powder inhalers.

Janwillem W H Kocks, Hans Wouters, Sinthia Bosnic-Anticevich, Joyce van Cooten, Jaime Correia de Sousa, Biljana Cvetkovski, Richard Dekhuijzen, Lars Dijk, Evgeni Dvortsin, Marina Garcia Pardo, Asparuh Gardev, Radosław Gawlik, Iris van Geer-Postmus, Iris van der Ham, Marten Harbers, Alberto de la Hoz, Ymke Janse, Marjan Kerkhof, Federico Lavorini, Tiago Maricoto, Jiska Meijer, Boyd Metz, David Price, Miguel Roman-Rodriguez, Kirsten Schuttel, Nilouq Stoker, Ioanna Tsiligianni, Omar Usmani, Marika T Leving

NPJ primary care respiratory medicine 2022;32(1):18

Free Full Text

Abstract

Dry powder inhaler of colistimethate sodium for lung infections in cystic fibrosis: optimization of powder construction.

Jana Kozáková, Ayça Altay, Vladimír Ždímal, Ludmila Mašková, Fabio Sonvico, Eride Quarta, Alessandra Rossi, Francesca Buttini, Gaia Colombo

Drug development and industrial pharmacy 2020;45(10):1664-1673

Full Text

Abstract

Inhaled gene delivery: a formulation and delivery approach.

Larissa Gomes Dos Reis, Maree Svolos, Benedikt Hartwig, Norbert Windhab, Paul M Young, Daniela Traini

Expert opinion on drug delivery 2017;14(3):319-330

Full Text

Abstract

Inhalable co-amorphous budesonide-arginine dry powders prepared by spray drying.

Wangding Lu, Thomas Rades, Jukka Rantanen, Mingshi Yang

International journal of pharmaceutics 2019;565():1-8

Full Text

Abstract

Dry powder inhalers in cystic fibrosis: same old drugs but different benefits?

Paul Tappenden, Lesley Uttley

Current opinion in pulmonary medicine 2015;20(6):607-12

Full Text

Abstract

Results: 1 – 15 / 29

Filters

Expert Opinion

Text Availability

Publication Types

Publication Year

Results for ""Dry Powder Inhalers""[mesh_terms]

Measuring Peak Inspiratory Flow in Patients with Chronic Obstructive Pulmonary Disease.

Safety, Tolerability, and Pharmacokinetics of a New Formulation of Nemiralisib Administered via a Dry Powder Inhaler to Healthy Individuals.

Solid Lipid Nanoparticle assemblies (SLNas) for an anti-TB inhalation treatment-A Design of Experiments approach to investigate the influence of pre-freezing conditions on the powder respirability.

Identifying critical inhalation technique errors in Dry Powder Inhaler use in patients with COPD based on the association with health status and exacerbations: findings from the multi-country cross-sectional observational PIFotal study.

Effect of inhaled dry powder mannitol on mucus and its clearance.

Suboptimal Peak Inspiratory Flow and Critical Inhalation Errors are Associated with Higher COPD-Related Healthcare Costs.

Computationally efficient analysis of particle transport and deposition in a human whole-lung-airway model. Part II: Dry powder inhaler application.

Use of a fundamental approach to spray-drying formulation design to facilitate the development of multi-component dry powder aerosols for respiratory drug delivery.

Colistimethate sodium dry powder for inhalation: a review of its use in the treatment of chronic Pseudomonas aeruginosa infection in patients with cystic fibrosis.

Clinical recommendations for dry powder inhaler use in the management of COPD in primary care.

Factors associated with health status and exacerbations in COPD maintenance therapy with dry powder inhalers.

Dry powder inhaler of colistimethate sodium for lung infections in cystic fibrosis: optimization of powder construction.

Inhaled gene delivery: a formulation and delivery approach.

Inhalable co-amorphous budesonide-arginine dry powders prepared by spray drying.

Dry powder inhalers in cystic fibrosis: same old drugs but different benefits?

Results for
""Dry Powder Inhalers""[mesh_terms]